View Future GrowthThis company listing is no longer activeThis company may still be operating, however this listing is no longer active. Find out why through their latest events.See Latest EventsNocturne Acquisition 과거 순이익 실적과거 기준 점검 0/6Nocturne Acquisition의 수입은 연평균 -55.9%의 비율로 감소해 온 반면, Capital Markets 산업의 수입은 연간 6.1% 증가했습니다.핵심 정보-55.90%순이익 성장률-1,313.73%주당순이익(EPS) 성장률Capital Markets 산업 성장률10.26%매출 성장률n/a자기자본이익률n/a순이익률n/a최근 순이익 업데이트30 Sep 2023최근 과거 실적 업데이트업데이트 없음모든 업데이트 보기Recent updates공시 • Apr 20Nocturne Acquisition Expects the Nasdaq Stock Market to File Form 25 with the United States Securities and Exchange Commission to Delist its SecuritiesNocturne Acquisition Corp. (‘Nocturne’ or the ‘Company’) announced that it will be unable to complete an initial business combination with Cognos Therapeutics Inc. (‘Cognos’) and intends to liquidate the Trust Account. In connection with the liquidation of the Trust Account, the Company will redeem all of the outstanding public shares of common stock (the ‘Public Shares’) at a per-share redemption price of approximately $11.79, after taking into account the removal of a portion of the accrued interest in the Trust Account to pay taxes and dissolution expenses. As of the close of business on or about April 18, 2024, the Public Shares will be deemed cancelled and stockholders will have the right to receive the redemption amount. In order to provide for the disbursement of funds from the Trust Account, the Company has instructed Continental Stock Transfer & Trust Company (‘Continental’), the trustee of the Trust Account, to take all necessary actions to liquidate the Trust Account. Record holders will receive their pro rata portion of the proceeds of the Trust Account by delivering their Public Shares to Continental, the Company's transfer agent. Beneficial owners of Public Shares held in ‘street name,’ however, will not need to take any action in order to receive the redemption amount. The redemption of the Public Shares is expected to be completed on or about April 18, 2024. The Company’s sponsor has agreed to waive its redemption rights with respect to its founder shares and private units. The Company expects that the Nasdaq Stock Market LLC will file a Form 25 with the United States Securities and Exchange Commission (the ‘SEC’) to delist the Company’s securities. The Company thereafter expects to file a Form 15 with the SEC to terminate the registration of its securities under the Securities Exchange Act of 1934, as amended.공시 • Apr 04Nocturne Acquisition Corporation(NasdaqCM:MBTC) dropped from NASDAQ Composite IndexNocturne Acquisition Corporation has been dropped from NASDAQ Composite Index .공시 • Apr 02+ 1 more updateNocturne Acquisition Corporation announced delayed annual 10-K filingOn 04/01/2024, Nocturne Acquisition Corporation announced that they will be unable to file their next 10-K by the deadline required by the SEC.Board Change • Mar 11High number of new directorsThere are 5 new directors who have joined the board in the last 3 years. Chief Strategy Officer & Director Liz Lin was the last director to join the board, commencing their role in 2024. The company’s lack of board continuity is considered a risk according to the Simply Wall St Risk Model.Board Change • Mar 01High number of new directorsThere are 5 new directors who have joined the board in the last 3 years. Chief Strategy Officer & Director Liz Lin was the last director to join the board, commencing their role in 2024. The company’s lack of board continuity is considered a risk according to the Simply Wall St Risk Model.공시 • Feb 08Nocturne Acquisition Corporation Announces Management ChangesOn February 1, 2024, Kashan Zaheer Piracha resigned from his position on the Board of Directors of Nocturne Acquisition Corporation, including his service on the Audit Committee of the Board and his chairmanship and service on the Compensation Committee of the Board. Mr. Piracha’s resignation was not the result of any dispute or disagreement with the Company or the Board on any matter relating to the Company’s operations, policies or practices. On February 2, 2024, the Board appointed Haoyu (Liz) Lin, 35, to serve as the Company’s Chief Strategy Officer and to a directorship position on the Board. The Board further appointed current director Ka Lok Wong to replace Mr. Piracha as a member of the Audit Committee and Chairman of the Compensation Committee. Ms. Lin has extensive experience with asset management and wealth management. Ms. Lin has served as Associate Director of Oneplatform Wealth Management Limited, owned by AGBA Group Holding Limited since April 2022. She has also served as Associate Director of OnePlatform Asset Management Limited of the same group since October 2023. Since September 2011, Ms. Lin has served as Associate Director at Convoy Global Holding Ltd. She received her BA from Wuhan University, MA from Hong Kong Baptist University and MBA from Tsinghua University. The Board believes Ms. Lin is well qualified to serve as its director due to her extensive experience in the financial industry.공시 • Jan 19Nocturne Acquisition Corporation Receives Notice from the Listing Qualifications Department of the Nasdaq Stock MarketOn January 8, 2024, Nocturne Acquisition Corporation (the Company"), received a notice from the Listing Qualifications Department of The Nasdaq Stock Market (Nasdaq") stating that the Company failed to hold an annual meeting of shareholders within 12 months after its fiscal year ended December 31, 2022, as required by Nasdaq Listing Rule 5620(a) (the Rule"). In accordance with Nasdaq Listing Rule 5810(c)(2)(G), the Company has 45 calendar days (or until February 22, 2024) to submit a plan to regain compliance and, if Nasdaq accepts the plan, Nasdaq may grant the Company up to 180 calendar days from its fiscal year end (or until June 28, 2024) to regain compliance. If Nasdaq does not accept the Company's plan, the Company will have the opportunity to appeal the decision in front of a Nasdaq Hearings Panel. The Company intends to submit a compliance plan within the specified period. While the plan is pending, the Company's securities will continue to trade on Nasdaq.공시 • Nov 14Nocturne Acquisition Corporation announced delayed 10-Q filingOn 11/13/2023, Nocturne Acquisition Corporation announced that they will be unable to file their next 10-Q by the deadline required by the SEC.Board Change • Nov 11High number of new directorsThere are 5 new directors who have joined the board in the last 3 years. Independent Director Derek Yiyi Feng was the last director to join the board, commencing their role in 2022. The company’s lack of board continuity is considered a risk according to the Simply Wall St Risk Model.공시 • Aug 13Nocturne Acquisition Corporation announced delayed 10-Q filingOn 08/11/2023, Nocturne Acquisition Corporation announced that they will be unable to file their next 10-Q by the deadline required by the SEC.공시 • Jun 07Nocturne Acquisition Receives Letter from the Listing Qualifications Department Staff of the Nasdaq as the Company No Longer Meets the Minimum 500,000 Publicly Held Shares Required for Continued Listing on the Nasdaq Capital Market Pursuant to Nasdaq Listing Rule 5550(a)(4)On May 31, 2023, Nocturne Acquisition Corporation received a letter (the “Public Float Notice”) from the listing qualifications department staff of The Nasdaq Stock Market (“Nasdaq”) notifying the Company that it no longer meets the minimum 500,000 publicly held shares required for continued listing on the Nasdaq Capital Market pursuant to Nasdaq Listing Rule 5550(a)(4) (the “Public Float Standard”). The Public Float Notice stated that the Company has until July 17, 2023 to provide Nasdaq with a specific plan to achieve and sustain compliance with all Nasdaq Capital Market listing requirements, including the time frame for completion of its plan. If Nasdaq does not accept the Company’s plan, the Company will have the opportunity to appeal that decision to a Nasdaq Hearings Panel. On April 3, 2023 at the extraordinary general meeting of the Company’s shareholders, the Company, in conjunction with a vote of the shareholders in favor of amending the organizational documents of the Company to extend the amount of time the Company has to complete a combination transaction (the “Extension Vote”), offered its shareholders the right to redeem public shares. The Company is in the process of confirming whether it currently satisfies the Public Float Standard, but believes that if it does not, the redemption of public shares in conjunction with the Extension Vote is what would have caused the Company to no longer be in compliance with the Public Float Standard. If the Company currently does not satisfy the Public Float Standard, it is expected that the surviving company in the Company’s previously announced, pending initial business combination with Cognos Therapeutics Inc. would satisfy the Public Float Standard immediately following the consummation of the initial business combination. The Public Float Notice has no immediate effect on the listing of the Company’s securities, and the Company’s securities continue to trade on the Nasdaq Capital Market. The Company intends to provide Nasdaq, on or prior to July 17, 2023, with the Company’s plan to meet the Public Float Standard, and will evaluate available options to regain compliance with the Public Float Standard. However, there can be no assurance that the Company will be able to regain compliance under the Public Float Standard, or will otherwise be in compliance with other Nasdaq listing criteria.공시 • May 31Nocturne Acquisition Announces Receipt of Second Notification from Nasdaq Due to Failure to File its Quarterly Report on Form 10-QNocturne Acquisition Corporation announced that it has received a second notification (the ‘Second Notification’) on May 24, 2023 from the Listing Qualifications Department of The Nasdaq Stock Market (‘Nasdaq’) as a result of its failure to file its Quarterly Report on Form 10-Q for the period ended March 31, 2023 (the ‘Form 10-Q’), and remaining delinquent in filing its Annual Report on Form 10-K for the period ended December 31, 2022 (the ‘Form 10-K’). The Second Notification advised the Company that it was not in compliance with Nasdaq's continued listing requirements under the timely filing criteria established in Nasdaq Listing Rule 5250(c)(1). The Company has since filed its Form 10-K, and is working diligently to complete and file the Form 10-Q as soon as practicable. In accordance with Nasdaq's letter dated April 21, 2023, the Company has until June 20, 2023, to submit a plan to regain compliance with respect to these delinquent reports. Please note that any Staff exception to allow the Company to regain compliance, if granted, will be limited to a maximum of 180 calendar days from the due date of the Initial Delinquent Filing, or October 16, 2023. However, there can be no assurance that Nasdaq will accept the Company's plan to regain compliance or that the Company will be able to regain compliance within any extension period granted by Nasdaq. If Nasdaq does not accept the Company's plan, then the Company will have the opportunity to appeal that decision to a Nasdaq hearings panel.공시 • May 16Nocturne Acquisition Corporation announced delayed 10-Q filingOn 05/15/2023, Nocturne Acquisition Corporation announced that they will be unable to file their next 10-Q by the deadline required by the SEC.공시 • May 04Nocturne Acquisition Corporation Receives Non-Compliance Notice From NasdaqOn April 21, 2023, Nocturne Acquisition Corporation (the “Company”) received a notification from Nasdaq that it was in violation of a Nasdaq continued listing requirement as it had failed to timely file its Annual Report on Form 10-K for the fiscal year ended December 31, 2022 (the “Form 10-K”). The notification provided that the Company had 60 days from the date of the letter to submit a plan to regain compliance with this continued listing requirement. The Company intends to file its 10-K imminently and bring itself back into compliance with the Nasdaq continued listing requirements.Board Change • Feb 15High number of new and inexperienced directorsThere are 7 new directors who have joined the board in the last 3 years. The company's board is composed of: 7 new directors. No experienced directors. No highly experienced directors. CFO & Director Thomas Ao is the most experienced director on the board, commencing their role in 2020. The following issues are considered to be risks according to the Simply Wall St Risk Model: Lack of board continuity. Lack of experienced directors.공시 • Jan 04Cognos Therapeutics Inc. executed a definitive business combination agreement to acquire Nocturne Acquisition Corporation (NasdaqCM:MBTC) for $120 million in a reverse merger transaction.Cognos Therapeutics Inc. executed a definitive business combination agreement to acquire Nocturne Acquisition Corporation (NasdaqCM:MBTC) for $120 million in a reverse merger transaction on January 3, 2023. Certain outstanding options and warrants to acquire capital stock of Cognos would be assumed by Nocturne. The transaction has been unanimously approved by the respective boards of directors of Cognos and Nocturne and is subject to approval by stockholders of Nocturne and Cognos and other customary closing conditions. The proposed business combination is expected to be completed in the second or third quarter of 2023. Maxim Group LLC served as sole financial advisor to Cognos in connection with the proposed business combination, and Newbridge Securities Corporation provided independent valuation advisory services to Nocturne. Ellenoff Grossman & Schole LLP served as legal advisor to Cognos and Dechert LLP served as legal advisor to Nocturne.공시 • Nov 16Nocturne Acquisition Corporation announced delayed 10-Q filingOn 11/15/2022, Nocturne Acquisition Corporation announced that they will be unable to file their next 10-Q by the deadline required by the SEC.공시 • Aug 16Nocturne Acquisition Corporation announced delayed 10-Q filingOn 08/15/2022, Nocturne Acquisition Corporation announced that they will be unable to file their next 10-Q by the deadline required by the SEC.공시 • Jul 06Nocturne Acquisition Corporation Announces Resignation of Etienne Snyman as Member of the BoardNocturne Acquisition Corporation announced that effective July 4, 2022, Etienne Snyman tendered his resignation as member of the Board. Mr. Snyman resigned due to a disagreement with the Company regarding the completion of the Extension.공시 • Jun 05Nocturne Acquisition Announces Receipt of Notice from Nasdaq Regarding Late Filing of Quarterly Report on Form 10-QNocturne Acquisition Corporation announced that it has received a notice ("Notice") from the Listing Qualifications Department of The Nasdaq Stock Market ("Nasdaq") as a result of its failure to file its Quarterly Report on Form 10-Q for the quarter ended March 31, 2021 (the "Form 10-Q") in a timely fashion. The Notice advised the Company that it was not in compliance with Nasdaq's continued listing requirements under the timely filing criteria established in Nasdaq Listing Rule 5250(c)(1). The Company is working diligently to complete its Form 10-Q. The Company intends to file it as soon as practicable to regain compliance with Nasdaq continued listing standards.공시 • May 18Nocturne Acquisition Corporation announced delayed 10-Q filingOn 05/17/2021, Nocturne Acquisition Corporation announced that they will be unable to file their next 10-Q by the deadline required by the SEC.매출 및 비용 세부 내역Nocturne Acquisition가 돈을 벌고 사용하는 방법. 최근 발표된 LTM 실적 기준.순이익 및 매출 추이NasdaqCM:MBTC 매출, 비용 및 순이익 (USD Millions)날짜매출순이익일반관리비연구개발비30 Sep 230-22030 Jun 230-13031 Mar 230-12031 Dec 220-12030 Sep 220-12030 Jun 220-11031 Dec 210-110양질의 수익: MBTC 은(는) 현재 수익성이 없습니다.이익 마진 증가: MBTC는 현재 수익성이 없습니다.잉여현금흐름 대비 순이익 분석과거 순이익 성장 분석수익추이: 지난 5년 동안 MBTC의 연간 수익 성장률이 양(+)이었는지 판단하기에 데이터가 부족합니다.성장 가속화: 현재 수익성이 없어 지난 1년간 MBTC의 수익 성장률을 5년 평균과 비교할 수 없습니다.수익 대 산업: MBTC은 수익성이 없어 지난 해 수익 성장률을 Capital Markets 업계(39.3%)와 비교하기 어렵습니다.자기자본이익률높은 ROE: MBTC의 부채가 자산을 초과하여 자본 수익률을 계산하기 어렵습니다.총자산이익률투하자본수익률우수한 과거 실적 기업을 찾아보세요7D1Y7D1Y7D1YDiversified-financials 산업에서 과거 실적이 우수한 기업.View Financial Health기업 분석 및 재무 데이터 상태데이터최종 업데이트 (UTC 시간)기업 분석2024/04/04 23:14종가2024/04/04 00:00수익2023/09/30연간 수익2022/12/31데이터 소스당사의 기업 분석에 사용되는 데이터는 S&P Global Market Intelligence LLC에서 제공됩니다. 아래 데이터는 이 보고서를 생성하기 위해 분석 모델에서 사용됩니다. 데이터는 정규화되므로 소스가 제공된 후 지연이 발생할 수 있습니다.패키지데이터기간미국 소스 예시 *기업 재무제표10년손익계산서현금흐름표대차대조표SEC 양식 10-KSEC 양식 10-Q분석가 컨센서스 추정치+3년재무 예측분석가 목표주가분석가 리서치 보고서Blue Matrix시장 가격30년주가배당, 분할 및 기타 조치ICE 시장 데이터SEC 양식 S-1지분 구조10년주요 주주내부자 거래SEC 양식 4SEC 양식 13D경영진10년리더십 팀이사회SEC 양식 10-KSEC 양식 DEF 14A주요 개발10년회사 공시SEC 양식 8-K* 미국 증권에 대한 예시이며, 비(非)미국 증권에는 해당 국가의 규제 서식 및 자료원을 사용합니다.별도로 명시되지 않는 한 모든 재무 데이터는 연간 기간을 기준으로 하지만 분기별로 업데이트됩니다. 이를 TTM(최근 12개월) 또는 LTM(지난 12개월) 데이터라고 합니다. 자세히 알아보기.분석 모델 및 스노우플레이크이 보고서를 생성하는 데 사용된 분석 모델에 대한 세부 정보는 당사의 Github 페이지에서 확인하실 수 있으며, 보고서 활용 방법에 대한 가이드와 YouTube 튜토리얼도 제공하고 있습니다.Simply Wall St 분석 모델을 설계하고 구축한 세계적 수준의 팀에 대해 알아보세요.산업 및 섹터 지표산업 및 섹터 지표는 Simply Wall St가 6시간마다 계산하며, 프로세스에 대한 자세한 내용은 Github에서 확인할 수 있습니다.분석가 소스Nocturne Acquisition Corporation는 0명의 분석가가 다루고 있습니다. 이 중 0명의 분석가가 우리 보고서에 입력 데이터로 사용되는 매출 또는 수익 추정치를 제출했습니다. 분석가의 제출 자료는 하루 종일 업데이트됩니다.
공시 • Apr 20Nocturne Acquisition Expects the Nasdaq Stock Market to File Form 25 with the United States Securities and Exchange Commission to Delist its SecuritiesNocturne Acquisition Corp. (‘Nocturne’ or the ‘Company’) announced that it will be unable to complete an initial business combination with Cognos Therapeutics Inc. (‘Cognos’) and intends to liquidate the Trust Account. In connection with the liquidation of the Trust Account, the Company will redeem all of the outstanding public shares of common stock (the ‘Public Shares’) at a per-share redemption price of approximately $11.79, after taking into account the removal of a portion of the accrued interest in the Trust Account to pay taxes and dissolution expenses. As of the close of business on or about April 18, 2024, the Public Shares will be deemed cancelled and stockholders will have the right to receive the redemption amount. In order to provide for the disbursement of funds from the Trust Account, the Company has instructed Continental Stock Transfer & Trust Company (‘Continental’), the trustee of the Trust Account, to take all necessary actions to liquidate the Trust Account. Record holders will receive their pro rata portion of the proceeds of the Trust Account by delivering their Public Shares to Continental, the Company's transfer agent. Beneficial owners of Public Shares held in ‘street name,’ however, will not need to take any action in order to receive the redemption amount. The redemption of the Public Shares is expected to be completed on or about April 18, 2024. The Company’s sponsor has agreed to waive its redemption rights with respect to its founder shares and private units. The Company expects that the Nasdaq Stock Market LLC will file a Form 25 with the United States Securities and Exchange Commission (the ‘SEC’) to delist the Company’s securities. The Company thereafter expects to file a Form 15 with the SEC to terminate the registration of its securities under the Securities Exchange Act of 1934, as amended.
공시 • Apr 04Nocturne Acquisition Corporation(NasdaqCM:MBTC) dropped from NASDAQ Composite IndexNocturne Acquisition Corporation has been dropped from NASDAQ Composite Index .
공시 • Apr 02+ 1 more updateNocturne Acquisition Corporation announced delayed annual 10-K filingOn 04/01/2024, Nocturne Acquisition Corporation announced that they will be unable to file their next 10-K by the deadline required by the SEC.
Board Change • Mar 11High number of new directorsThere are 5 new directors who have joined the board in the last 3 years. Chief Strategy Officer & Director Liz Lin was the last director to join the board, commencing their role in 2024. The company’s lack of board continuity is considered a risk according to the Simply Wall St Risk Model.
Board Change • Mar 01High number of new directorsThere are 5 new directors who have joined the board in the last 3 years. Chief Strategy Officer & Director Liz Lin was the last director to join the board, commencing their role in 2024. The company’s lack of board continuity is considered a risk according to the Simply Wall St Risk Model.
공시 • Feb 08Nocturne Acquisition Corporation Announces Management ChangesOn February 1, 2024, Kashan Zaheer Piracha resigned from his position on the Board of Directors of Nocturne Acquisition Corporation, including his service on the Audit Committee of the Board and his chairmanship and service on the Compensation Committee of the Board. Mr. Piracha’s resignation was not the result of any dispute or disagreement with the Company or the Board on any matter relating to the Company’s operations, policies or practices. On February 2, 2024, the Board appointed Haoyu (Liz) Lin, 35, to serve as the Company’s Chief Strategy Officer and to a directorship position on the Board. The Board further appointed current director Ka Lok Wong to replace Mr. Piracha as a member of the Audit Committee and Chairman of the Compensation Committee. Ms. Lin has extensive experience with asset management and wealth management. Ms. Lin has served as Associate Director of Oneplatform Wealth Management Limited, owned by AGBA Group Holding Limited since April 2022. She has also served as Associate Director of OnePlatform Asset Management Limited of the same group since October 2023. Since September 2011, Ms. Lin has served as Associate Director at Convoy Global Holding Ltd. She received her BA from Wuhan University, MA from Hong Kong Baptist University and MBA from Tsinghua University. The Board believes Ms. Lin is well qualified to serve as its director due to her extensive experience in the financial industry.
공시 • Jan 19Nocturne Acquisition Corporation Receives Notice from the Listing Qualifications Department of the Nasdaq Stock MarketOn January 8, 2024, Nocturne Acquisition Corporation (the Company"), received a notice from the Listing Qualifications Department of The Nasdaq Stock Market (Nasdaq") stating that the Company failed to hold an annual meeting of shareholders within 12 months after its fiscal year ended December 31, 2022, as required by Nasdaq Listing Rule 5620(a) (the Rule"). In accordance with Nasdaq Listing Rule 5810(c)(2)(G), the Company has 45 calendar days (or until February 22, 2024) to submit a plan to regain compliance and, if Nasdaq accepts the plan, Nasdaq may grant the Company up to 180 calendar days from its fiscal year end (or until June 28, 2024) to regain compliance. If Nasdaq does not accept the Company's plan, the Company will have the opportunity to appeal the decision in front of a Nasdaq Hearings Panel. The Company intends to submit a compliance plan within the specified period. While the plan is pending, the Company's securities will continue to trade on Nasdaq.
공시 • Nov 14Nocturne Acquisition Corporation announced delayed 10-Q filingOn 11/13/2023, Nocturne Acquisition Corporation announced that they will be unable to file their next 10-Q by the deadline required by the SEC.
Board Change • Nov 11High number of new directorsThere are 5 new directors who have joined the board in the last 3 years. Independent Director Derek Yiyi Feng was the last director to join the board, commencing their role in 2022. The company’s lack of board continuity is considered a risk according to the Simply Wall St Risk Model.
공시 • Aug 13Nocturne Acquisition Corporation announced delayed 10-Q filingOn 08/11/2023, Nocturne Acquisition Corporation announced that they will be unable to file their next 10-Q by the deadline required by the SEC.
공시 • Jun 07Nocturne Acquisition Receives Letter from the Listing Qualifications Department Staff of the Nasdaq as the Company No Longer Meets the Minimum 500,000 Publicly Held Shares Required for Continued Listing on the Nasdaq Capital Market Pursuant to Nasdaq Listing Rule 5550(a)(4)On May 31, 2023, Nocturne Acquisition Corporation received a letter (the “Public Float Notice”) from the listing qualifications department staff of The Nasdaq Stock Market (“Nasdaq”) notifying the Company that it no longer meets the minimum 500,000 publicly held shares required for continued listing on the Nasdaq Capital Market pursuant to Nasdaq Listing Rule 5550(a)(4) (the “Public Float Standard”). The Public Float Notice stated that the Company has until July 17, 2023 to provide Nasdaq with a specific plan to achieve and sustain compliance with all Nasdaq Capital Market listing requirements, including the time frame for completion of its plan. If Nasdaq does not accept the Company’s plan, the Company will have the opportunity to appeal that decision to a Nasdaq Hearings Panel. On April 3, 2023 at the extraordinary general meeting of the Company’s shareholders, the Company, in conjunction with a vote of the shareholders in favor of amending the organizational documents of the Company to extend the amount of time the Company has to complete a combination transaction (the “Extension Vote”), offered its shareholders the right to redeem public shares. The Company is in the process of confirming whether it currently satisfies the Public Float Standard, but believes that if it does not, the redemption of public shares in conjunction with the Extension Vote is what would have caused the Company to no longer be in compliance with the Public Float Standard. If the Company currently does not satisfy the Public Float Standard, it is expected that the surviving company in the Company’s previously announced, pending initial business combination with Cognos Therapeutics Inc. would satisfy the Public Float Standard immediately following the consummation of the initial business combination. The Public Float Notice has no immediate effect on the listing of the Company’s securities, and the Company’s securities continue to trade on the Nasdaq Capital Market. The Company intends to provide Nasdaq, on or prior to July 17, 2023, with the Company’s plan to meet the Public Float Standard, and will evaluate available options to regain compliance with the Public Float Standard. However, there can be no assurance that the Company will be able to regain compliance under the Public Float Standard, or will otherwise be in compliance with other Nasdaq listing criteria.
공시 • May 31Nocturne Acquisition Announces Receipt of Second Notification from Nasdaq Due to Failure to File its Quarterly Report on Form 10-QNocturne Acquisition Corporation announced that it has received a second notification (the ‘Second Notification’) on May 24, 2023 from the Listing Qualifications Department of The Nasdaq Stock Market (‘Nasdaq’) as a result of its failure to file its Quarterly Report on Form 10-Q for the period ended March 31, 2023 (the ‘Form 10-Q’), and remaining delinquent in filing its Annual Report on Form 10-K for the period ended December 31, 2022 (the ‘Form 10-K’). The Second Notification advised the Company that it was not in compliance with Nasdaq's continued listing requirements under the timely filing criteria established in Nasdaq Listing Rule 5250(c)(1). The Company has since filed its Form 10-K, and is working diligently to complete and file the Form 10-Q as soon as practicable. In accordance with Nasdaq's letter dated April 21, 2023, the Company has until June 20, 2023, to submit a plan to regain compliance with respect to these delinquent reports. Please note that any Staff exception to allow the Company to regain compliance, if granted, will be limited to a maximum of 180 calendar days from the due date of the Initial Delinquent Filing, or October 16, 2023. However, there can be no assurance that Nasdaq will accept the Company's plan to regain compliance or that the Company will be able to regain compliance within any extension period granted by Nasdaq. If Nasdaq does not accept the Company's plan, then the Company will have the opportunity to appeal that decision to a Nasdaq hearings panel.
공시 • May 16Nocturne Acquisition Corporation announced delayed 10-Q filingOn 05/15/2023, Nocturne Acquisition Corporation announced that they will be unable to file their next 10-Q by the deadline required by the SEC.
공시 • May 04Nocturne Acquisition Corporation Receives Non-Compliance Notice From NasdaqOn April 21, 2023, Nocturne Acquisition Corporation (the “Company”) received a notification from Nasdaq that it was in violation of a Nasdaq continued listing requirement as it had failed to timely file its Annual Report on Form 10-K for the fiscal year ended December 31, 2022 (the “Form 10-K”). The notification provided that the Company had 60 days from the date of the letter to submit a plan to regain compliance with this continued listing requirement. The Company intends to file its 10-K imminently and bring itself back into compliance with the Nasdaq continued listing requirements.
Board Change • Feb 15High number of new and inexperienced directorsThere are 7 new directors who have joined the board in the last 3 years. The company's board is composed of: 7 new directors. No experienced directors. No highly experienced directors. CFO & Director Thomas Ao is the most experienced director on the board, commencing their role in 2020. The following issues are considered to be risks according to the Simply Wall St Risk Model: Lack of board continuity. Lack of experienced directors.
공시 • Jan 04Cognos Therapeutics Inc. executed a definitive business combination agreement to acquire Nocturne Acquisition Corporation (NasdaqCM:MBTC) for $120 million in a reverse merger transaction.Cognos Therapeutics Inc. executed a definitive business combination agreement to acquire Nocturne Acquisition Corporation (NasdaqCM:MBTC) for $120 million in a reverse merger transaction on January 3, 2023. Certain outstanding options and warrants to acquire capital stock of Cognos would be assumed by Nocturne. The transaction has been unanimously approved by the respective boards of directors of Cognos and Nocturne and is subject to approval by stockholders of Nocturne and Cognos and other customary closing conditions. The proposed business combination is expected to be completed in the second or third quarter of 2023. Maxim Group LLC served as sole financial advisor to Cognos in connection with the proposed business combination, and Newbridge Securities Corporation provided independent valuation advisory services to Nocturne. Ellenoff Grossman & Schole LLP served as legal advisor to Cognos and Dechert LLP served as legal advisor to Nocturne.
공시 • Nov 16Nocturne Acquisition Corporation announced delayed 10-Q filingOn 11/15/2022, Nocturne Acquisition Corporation announced that they will be unable to file their next 10-Q by the deadline required by the SEC.
공시 • Aug 16Nocturne Acquisition Corporation announced delayed 10-Q filingOn 08/15/2022, Nocturne Acquisition Corporation announced that they will be unable to file their next 10-Q by the deadline required by the SEC.
공시 • Jul 06Nocturne Acquisition Corporation Announces Resignation of Etienne Snyman as Member of the BoardNocturne Acquisition Corporation announced that effective July 4, 2022, Etienne Snyman tendered his resignation as member of the Board. Mr. Snyman resigned due to a disagreement with the Company regarding the completion of the Extension.
공시 • Jun 05Nocturne Acquisition Announces Receipt of Notice from Nasdaq Regarding Late Filing of Quarterly Report on Form 10-QNocturne Acquisition Corporation announced that it has received a notice ("Notice") from the Listing Qualifications Department of The Nasdaq Stock Market ("Nasdaq") as a result of its failure to file its Quarterly Report on Form 10-Q for the quarter ended March 31, 2021 (the "Form 10-Q") in a timely fashion. The Notice advised the Company that it was not in compliance with Nasdaq's continued listing requirements under the timely filing criteria established in Nasdaq Listing Rule 5250(c)(1). The Company is working diligently to complete its Form 10-Q. The Company intends to file it as soon as practicable to regain compliance with Nasdaq continued listing standards.
공시 • May 18Nocturne Acquisition Corporation announced delayed 10-Q filingOn 05/17/2021, Nocturne Acquisition Corporation announced that they will be unable to file their next 10-Q by the deadline required by the SEC.